The news lands like a show-cause on a vanity plate: three of Hindi cinema's most bankable stars — Shah Rukh Khan, Ajay Devgn and Tiger Shroff — have reportedly been pulled up by the FDA over the Vimal Elaichi advertisement. If confirmed, it would be one of the most high-profile regulatory actions against celebrity endorsers of a pan masala brand.
What the exclusive report says
According to the exclusive report, the Food and Drug Administration has issued showcause notices to Shah Rukh Khan, Ajay Devgn and Tiger Shroff in connection with the Vimal Elaichi ad.
The notice reportedly questions their endorsement of the product. Neither the exact wording nor the specific grounds cited in the notice have been made public so far.
None of the three actors, the brand, or the FDA has released an official statement at the time of writing.
Why a pan masala endorsement has regulators interested
Pan masala advertising occupies a legally sensitive space in India. While some variants are sold as consumer food products, others are associated with tobacco — a category that faces strict advertising restrictions under Indian law.
Beyond that, the Consumer Protection Act, 2019 holds endorsers accountable for misleading advertisements, with the possibility of fines and a temporary ban from future endorsements. That backdrop gives any FDA showcause notice to top actors unusual legal weight.
What remains unclear right now
Key details are still missing. It is not known which state FDA or regulatory wing issued the notices, when they were sent, or what deadline the actors have been given to respond.
Until the notices or official statements surface, this development should be treated as an unconfirmed exclusive rather than a settled regulatory finding.
A familiar pressure point in celebrity advertising
Indian regulators have previously trained their focus on celebrities endorsing pan masala and tobacco-adjacent products, reminding stars that brand power carries legal responsibility.
This case, if confirmed, shows that scrutiny has not faded — and that star power rarely shields endorsers from the regulator's office.
What the actors and the brand could face next
The immediate next step lies with the actors and the advertiser: a formal response explaining the endorsement, including any due diligence done before signing.
Depending on the reply and the legal category the product falls under, the matter could close with a warning, escalate into broader regulatory action, or become a test case for celebrity accountability in advertising.
Our Take
Three A-list actors receiving showcause notices for a single ad would be a significant signal — not because audiences will stop watching their films, but because it would remind every celebrity that endorsement is no longer just a business deal. In India's tightening consumer-protection regime, it is a legal commitment. The next statements from the actors and the FDA will decide whether this is a passing notice or a turning point.
Frequently Asked Questions
Why did Shah Rukh Khan, Ajay Devgn and Tiger Shroff get FDA showcause notices?
According to an exclusive report, the FDA issued showcause notices to the three actors over the Vimal Elaichi advertisement. The specific grounds have not been made public, and official confirmation is awaited.
What is a showcause notice?
A showcause notice is a formal legal document asking the recipient to explain why action should not be taken against them. The recipient must respond within a set timeframe, after which the regulator decides the next course.
Can celebrities be penalised for endorsing pan masala products?
Yes. Under Indian consumer law, endorsers of misleading advertisements can face fines and a temporary ban from future endorsements. Advertising rules also restrict promotion of tobacco-adjacent products.
Has the FDA or any actor confirmed this notice?
No. Neither the FDA, Shah Rukh Khan, Ajay Devgn, Tiger Shroff, nor the Vimal brand has issued an official confirmation or response. The report remains unverified until official documents emerge.
